Organo

The Rohm and Haas alliance: sole agent for Amberlite in Japan (1951)

Key decision·1951· Organo — the full company history →

What it learned while borrowing someone else’s technology

What Nihon Organo Shokai set out to secure was not manufacturing technology but the very substance inside the equipment it sold. For a business that packs resin into a cylinder and sells it, the performance and the available volume of that resin set the ceiling on the whole enterprise. President Maruyama Masatake was an engineer who had researched ion-exchange resins at the Army Medical School, and he knew better than anyone that the quality of the equipment is bound by its material. The decision converted a position of buying from Mitsubishi Chemical into trade with a partner of its own choosing.

Yet the alliance was also an admission of the technology gap of the moment. Rather than taking the route of making resin itself first, the company started by handling an imported product, and it took six years to reach a domestic one. Of the contract nothing survives beyond the single phrase “sole agent in Japan” in the official history — neither the consideration nor the terms can be traced. During those six years its pure-water equipment had travelled from Showa Denko’s Okawa works to high-purity water for NEC’s electronics. A decision to borrow another company’s technology takes its meaning, after the fact, from what was learned while the borrowing lasted.

Revenue and net margin, FY1946–FY1956

Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1951 onwards — after it was taken.

Source: securities reports

Read the full dossier in Japanese →

The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.


Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →


Disclaimer

  • This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
  • Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
  • Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
  • Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
  • Company names, logos and other marks belong to their respective owners.

Data API

Organo’s history, financials, executives and shareholders are published as static JSON — no key, plain GET. Full specification →

Method Endpoint Returns
GET /api/companies.json All companies
GET /api/6368/manifest.json Resource index
GET /api/6368/history.json History overview
GET /api/6368/timeline.json Chronology
GET /api/decisions.json All management decisions (index)
GET /api/6368/decisions.json Management decisions (index)
GET /api/6368/decisions/{slug}.json One decision (full dossier)
GET /api/6368/executives.json Executives
GET /api/6368/shareholders.json Major shareholders
GET /api/6368/financials.json Financial statements
GET /api/6368/financials-longterm.json Long-term results
GET /api/6368/segments.json Business segments
GET /api/6368/regions.json Sales by region
GET /api/6368/workforce.json Workforce